Confident young woman gesturing while teaching students in class

Submit your research

Start your submission and get more impact for your research by publishing with us.

Active senior woman concentrating while working on laptop

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Front view portrait of African American man wearing lab coat and raising hand asking question while sitting in audience and listening to lecture on medicine

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Smiling colleagues doing research over laptop computer on desk in office

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Interior of a library with desks and bookshelves

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Editors

See all (653)

bruno villoutreix

Institut National de la Santé et de la Recherche Médicale (INSERM)

Paris, France

Field Chief Editor

Frontiers in Drug Discovery
vicky m avery

Griffith University

Nathan, Australia

Specialty Chief Editor

Anti-Cancer Drugs
paula gomes

University of Porto

Porto, Portugal

Specialty Chief Editor

Anti-Infective Agents
charles c hong

School of Medicine, University of Maryland

Baltimore, United States

Specialty Chief Editor

Cardiovascular and Hematologic Drugs

Frontiers in Drug Discovery

Submit your research

Author guidelines

Editor guidelines

Peer review

Publishing fees

Editors

bruno villoutreix

vicky m avery

paula gomes

charles c hong

Articles

Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease

The use of cyclic peptide antigens to generate LRP8 specific antibodies

In silico mapping of the dynamic interactions and structure-activity relationship of flavonoid compounds against the immune checkpoint programmed-cell death 1 pathway

Zingiber officinale (Ginger) as a treatment for inflammatory bowel disease: A review of current literature

Volumes

Research Topics

Discover and Design: Emerging Targeted Protein Degradation (TPD) Approaches and Modalities for Cancer Treatment

Recent Advances in the Design of PROTACs for Inducing Protein Degradation

Bringing the Structure Inactivity-Relationships on Drug Discovery: Importance of Inactive and Negative Data

Drug Discovery and Development Explained: Introductory Notes for the General Public